Home Compare VRSK vs VRTX
Stock Comparison · Single-driver result

Verisk Analytics vs Vertex Pharmaceuticals: Which Stock Looks Stronger in 2026?

The structural profiles are close, with Verisk Analytics carrying a narrow edge on stability. Vertex Pharmaceuticals still has the edge on stability, which keeps the comparison from looking entirely one-sided. Both sides have seen trend damage — neither carries a clear market edge right now. With both trends damaged, the structural comparison carries most of the weight here.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

Stability points more clearly toward Vertex Pharmaceuticals Incorporated, even if the broader score still leans toward Verisk Analytics, Inc..

Trajectory Similarity
0.58
Moderately similar
Peer-set rank: #35
within Verisk Analytics, Inc.'s functional peer set

This comparison is anchored in long-term financial trajectory similarity within the selected peer universe.

The pair shares a valid long-term profile match, but the trajectories are not especially close.

The strongest overlap appears in revenue stability and capital structure.

Similarity drivers
revenue stabilitycapital structure
What reduces the match
margin consistency
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
VRSK
Verisk Analytics, Inc.
75
Peer-Score
Signal qualityMedium
vs
VRTX
Vertex Pharmaceuticals Incorporated
71
Peer-Score
Signal qualityHigh

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

The clearest separation appears in stability.

Dimension spread: VRSK vs VRTX Profitability 100 78 Stability 53 76 Valuation 69 68 Growth 67 61 VRSK VRTX
Gap Ranking
#1 Stability +23
#2 Profitability +22
#3 Growth +6
#4 Valuation +1
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for VRSK and VRTX Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer VRSKVRTX Relative valuation Structural strength

The setup stays mixed because structure and the price setup do not align cleanly in one direction.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Stability
Both look solid on stability, though Vertex Pharmaceuticals Incorporated still holds the stronger peer position.
Profitability
On profitability, the edge still sits with Verisk Analytics, Inc., even though both profiles look solid.
Stability — Dominant Gap
VRSK
53
VRTX
76
Gap+23in favour of VRTX

The clearest distance comes from a steadier profile over time.

What else supports the lead

Capital efficiency adds support, with a 6.2-point ROIC advantage.

What this means for the comparison

Stability is the clearest driver of the lead, with profitability adding further support — though stability still provides a real counterweight.

Explore full peer positioning in AssetNext

Break down the VRSK vs VRTX comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Other comparisons with conflicting dimension signals

Explore how VRSK and VRTX each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.